"Wir sind ein international anerkanntes Fachkrankenhaus und wichtiger Akutversorger im Landkreis Karlsruhe. Mit modernster Medizin, umfassender Pflege und individueller Therapie behandeln gesetzlich und privat versicherte Patient:innen in oft lebensverändernden Situationen. Damit unsere Patient:innen genau die Therapie bekommen, die für sie am besten ist, investieren wir in unsere Mitarbeiter:innen, in eine effektive Infrastruktur und innovative Medizintechnik. Außerdem haben wir uns spezialisiert: Der fachübergreifende Behandlungsansatz und unser tiefgehendes Verständnis in den Fachgebieten Muskeln & Skelett, Herz & Gefäße, Nervensystem sowie Psyche ermöglichen es uns, bestimmte Krankheitsbilder besser, sicherer und gezielter zu behandeln."

During the past decade, SRH Klinikum Karlsbad-Langensteinbach conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SRH Klinikum Karlsbad-Langensteinbach" #1 sponsor was "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Arteriogenesis Competence Network" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SRH Klinikum Karlsbad-Langensteinbach" #1 collaborator was "BARMER GEK Germany" with 1 trials as a collaborator, "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "GermanVasc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "SRH Klinikum Karlsbad-Langensteinbach" are "Peripheral Arterial Disease" (4 trials), "Hypercholesterolemia" (2 trials), "Acute Coronary Syndrome" (1 trials), "Arterial Occlusive Disease" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "SRH Klinikum Karlsbad-Langensteinbach" in a lesser frequency.

Most popular intervention types in "SRH Klinikum Karlsbad-Langensteinbach" are "Drug" (8 trials), "Device" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Edoxaban" (2 trials), "Aspirin" (1 trials), "Basic Cognitive Training" (1 trials), "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials) and "Bypass-Surgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "SRH Klinikum Karlsbad-Langensteinbach" are 16 trials for "All" genders.

Currently, there are NaN active trials in "SRH Klinikum Karlsbad-Langensteinbach". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in SRH Klinikum Karlsbad-Langensteinbach, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in SRH Klinikum Karlsbad-Langensteinbach, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".